Stem Cell Company Athersys Gets Grant to Study Traumatic Brain Injury

Athersys has received NINDS support to develop its MultiStem technology for the treatment of traumatic brain injury. Support for Athersys’s program comes at a crucial time for stem cell therapeutics in the neurodegenerative disease space, following Geron’s recent exit from the stem cell arena. (http://www.nytimes.com/2011/11/15/business/geron-is-shutting-down-its-stem-cell-clinical-trial.html).

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail